Publications by authors named "Kazue Haikawa"
Article Synopsis
- The investigational drug pevonedistat, in combination with azacitidine, is being tested for higher-risk myelodysplastic syndrome (MDS), chronic myelomonocytic leukemia (CMML), and low-blast acute myeloid leukemia (AML) in a Phase 3 trial named PANTHER.
- The study confirms that drug and disease factors related to MDS and AML are similar in both Western and East Asian populations, supporting the inclusion of diverse participants for global trial results.
- Both regions show comparable efficacy and tolerability for the treatments, with the aim of enrolling around 30 East Asian patients out of 450 total participants to ensure consistency in outcomes.
